ERBB2 and breast cancer: The following clinicopathological characteristics were considered in this regard: age at diagnosis, nulliparity, breastfeeding history, family history, size of the primary tumor, tumor grade, histological type of breast cancer, hormonal receptors, HER2, multifocality, lymph node status, presence of metastasis at diagnosis, tumor stage, and the five-year survival rate.